Type B lesions are frequently positive for neuroendocrine markers (e.g., synaptophysin, chromogranin A, CD56) [6,7], and the surrounding tissues often have ductal carcinoma in situ (DCIS) components with a neuroendocrine tendency, which are considered precursor lesions [8]. This evidence concerns the gene NCAM1 and ductal breast carcinoma in situ.